Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | CPT2 | P23786 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20526404 | 1.00 | TDP1 (0.36) | TDP1FFAR1CPT2TSHRALDH1A1 | |
| SCHEMBL1840460 | 1.00 | TDP1 (0.36) | TDP1FFAR1CPT2TSHRALDH1A1 | |
| SCHEMBL1834611 | 1.00 | TDP1 (0.36) | TDP1FFAR1CPT2TSHRALDH1A1 | |
| SCHEMBL27583386 | 1.00 | TDP1 (0.36) | TDP1FFAR1CPT2TSHRALDH1A1 | |
| SCHEMBL1845796 | 1.00 | TDP1 (0.36) | TDP1FFAR1CPT2TSHRALDH1A1 | |
| SCHEMBL20509901 | 1.00 | TDP1 (0.36) | TDP1FFAR1CPT2TSHRALDH1A1 | |
| SCHEMBL3291304 | 1.00 | TDP1 (0.36) | TDP1FFAR1CPT2TSHRALDH1A1 | |
| SCHEMBL4580892 | 0.95 | TDP1 (0.39) | TDP1FFAR1CPT2TSHRALDH1A1 | |
| Fluoride SCHEMBL11519479 | 0.91 | TDP1 (0.36) | TDP1FFAR1CPT2TSHRALDH1A1 | |
| SCHEMBL1615049 | 0.86 | TSHR (0.39) | TDP1TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2004532799-A | — | — | 2004-10-28 | — | — | JP | claimed |
| EP-1363879-A2 | SULFIDE AND DISULFIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | Esperion Therapeutics Inc. (US) | 2003-11-26 | — | — | EP | claimed |
| WO-2002030884-A2 | SULFIDE AND DISULFIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | ESPERION THERAPEUTICS, INC. (US) | 2002-04-18 | — | — | WO | claimed |
| WO-2024107762-A2 | DECREASED RETENTION OF MINIPROTEINS IN KIDNEY | AKTIS ONCOLOGY, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024010957-A2 | NECTIN-4 MINIPROTEIN CONJUGATES | AKTIS ONCOLOGY, INC. (US) | 2024-01-11 | — | — | WO | disclosed |
| CN-1479712-A | Ketone compounds and compositions for cholesterol management and related uses | ͨ��ҽ�ƹ�˾ | 2004-03-03 | — | — | CN | disclosed |